Cycling the wagons for biliverdin reductase.
Sedlak
Thomas W
TW
Snyder
Solomon H
SH
D000975:Antioxidants / Q000378:metabolism*; D001664:Biliverdine / Q000235:genetics / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000378:metabolism* / Q000473:pathology; D002561:Cerebrovascular Disorders / Q000378:metabolism* / Q000473:pathology; D006367:HeLa Cells; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D015227:Lipid Peroxidation / Q000187:drug effects / Q000502:physiology; D009154:Mutation; D016877:Oxidants / Q000494:pharmacology; D044925:Oxidoreductases Acting on CH-CH Group Donors / Q000235:genetics / Q000378:metabolism*; D010544:Peroxidases / Q000235:genetics / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000201:enzymology / Q000235:genetics; D029701:Saccharomyces cerevisiae Proteins / Q000235:genetics / Q000378:metabolism
D000975:Antioxidants; D016877:Oxidants; D029701:Saccharomyces cerevisiae Proteins; D006861:Hydrogen Peroxide; C478774:HMX1 protein, S cerevisiae; D010544:Peroxidases; D044925:Oxidoreductases Acting on CH-CH Group Donors; C019789:biliverdin reductase; D001664:Biliverdine